VAERS 2408270
SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ525AAB
- Staat
- AZ
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.08.2022
- Impfdatum
- -
- Beginn
- 22.07.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Symptomtext
patient was administered the vaccine on 7/22/2022,the same form listed an exp date for the product of 7/11/2022 with no reported adverse event; Initial information received on 03-Aug-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves an unknown age and unknown gender patient who was administered the vaccine on 7/22/2022,the same form listed an exp date for the product of 7/11/2022 with no reported adverse event involving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5ml 1X(once) dose of suspect HIB (PRP/T) VACCINE (strength, formulation was unknown, lot UJ525AAB and expiry date: 11-Jul-2022) via unknown route in unknown administration site for Immunization. It was reported that the patient developed a non-serious event was administered the vaccine, the same form listed an exp date for the product of 11-Jul-2022 with no reported adverse event (expired product administered) (onset date: 22-Jul-2022, latency: same day) following the administration of HIB (PRP/T) VACCINE. They received the vaccination report for the patient and the expiry date listed falls about 11 days before the vaccination was administered. They were asking if we can confirm the expiration date based on the lot number of the product, and how to proceed from here. Reporter does not have the actual product so they cannot see the date on the package, it was located at another pharmacy that administered the vaccine. Action taken with HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -